Dr Elena De Vita
Lecturer in Synthetic Biology and Biotechnology
Lead for ECR & Research Environment
School of Biological and Behavioural Sciences
Queen Mary University of London
Research
Chemical Biology, Covalent ligands, Induced Proximity, PHOSTACs/ PROTACs, Drug Discovery and High throughput screening, Cancer Biology
Interests
Building on our expertise in covalent ligand discovery and chemical biology, the De Vita group develops chemical tools to interrogate challenging protein targets and uncover their roles in cellular function and disease. Our research sits at the interface of chemical biology, medicinal chemistry and cancer biology, with a particular interest in developing and using covalent ligands to investigate biological mechanisms that are difficult to address using conventional approaches.
A major focus of the group is the development of covalent chemical probes for challenging targets, including small GTPases and protein phosphatases. We combine structure-guided ligand discovery, chemical proteomics and cellular assays to establish target engagement, dissect protein function and uncover new mechanisms of disease biology.
Our current research interests also include chemically induced proximity approaches, such as targeted protein degradation and targeted protein dephosphorylation using bifunctional ligands that recruit protein phosphatases to specific phosphorylated proteins. We use these chemical tools not only to explore new therapeutic opportunities, but also to answer fundamental questions in cancer biology and understand how protein function and cellular signalling can be controlled with chemical precision.
Publications

Publications of specific relevance to the Centre for Molecular Cell Biology
2026
Introducing the 2026 Early Career Board of ACS Medicinal Chemistry LettersAxtman A Goldstein S Hlozek J Monti L Shen C Shevick SL Uguen M Vukelic S et al.
Acs Medicinal Chemistry Letters,
American Chemical Society (Acs) vol. 17 (5), 955-960.
04-05-2026
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerabilityD’Ambrosio M White MEH Gavriil ES Bousset L Birch J Gruevska A Pasquini E Colucci M et al.
Nature Cell Biology,
Springer Nature vol. 28 (5), 915-929.
24-04-20262025
Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivoDe Vita E
Acta Pharmaceutica Sinica B,
Elsevier vol. 15 (10), 5491-5492.
01-10-2025
The phosphate of lifeDe Vita E Page R
Nature Chemistry,
Springer Nature vol. 17 (3), 460-460.
01-03-20252024
What is chemical biology?Antolin AA Aye Y Bar-Peled L De Vita E Dudkina N Jewett MC Kiely-Collins H Mazitschek R et al.
Cell Chemical Biology,
Elsevier vol. 31 (9), 1562-1565.
01-09-2024
Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACsShah RR De Vita E Sathyamurthi PS Conole D Zhang X Fellows E Dickinson ER Fleites CM et al.
Journal of Medicinal Chemistry,
American Chemical Society (Acs) vol. 67 (6), 4641-4654.
13-03-20242022
A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell InvasionZhang L Lovell S De Vita E Jagtap PKA Lucy D Grocin AG Kjær S Borg A et al.
Journal of The American Chemical Society,
American Chemical Society (Acs) vol. 144 (49), 22493-22504.
22-11-2022
Identification of the first structurally validated covalent ligands of the small GTPase RAB27AJamshidiha M Lanyon-Hogg T Sutherell CL Craven GB Tersa M De Vita E Brustur D Pérez-Dorado I et al.
Rsc Medicinal Chemistry,
Royal Society of Chemistry (Rsc) vol. 13 (2), 150-155.
01-01-2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)Zhang Q Kounde CS Mondal M Greenfield JL Baker JR Kotelnikov S Ignatov M Tinworth CP et al.
Chemical Communications,
Royal Society of Chemistry (Rsc) vol. 58 (78), 10933-10936.
01-01-20222021
Blocking Kallikrein 6 promotes developmental myelinationYoon H Triplet EM Simon WL Choi C Kleppe LS De Vita E Miller AK Scarisbrick IA
Glia,
Wiley vol. 70 (3), 430-450.
09-10-2021
Beyond targeted protein degradation: LD·ATTECs clear cellular lipid dropletsDe Vita E Lucy D Tate EW
Cell Research,
Springer Nature vol. 31 (9), 945-946.
05-08-2021
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate CancerLovell S Zhang L Kryza T Neodo A Bock N De Vita E Williams ED Engelsberger E et al.
Journal of The American Chemical Society,
American Chemical Society (Acs) vol. 143 (23), 8911-8924.
04-06-2021
Development of a fluorogenic ADAMTS-7 substrateSantamaria S Buemi F Nuti E Cuffaro D De Vita E Tuccinardi T Rossello A Howell S et al.
Journal of Enzyme Inhibition and Medicinal Chemistry,
Taylor & Francis vol. 36 (1), 2160-2169.
01-01-2021
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugsManeiro M De Vita E Conole D Kounde CS Zhang Q Tate EW
67-190.
01-01-20212020
10 years into the resurgence of covalent drugsDe Vita E
Future Medicinal Chemistry,
Taylor & Francis vol. 13 (2), 193-210.
04-12-2020
The Missing Link between (Un)druggable and Degradable KRASDe Vita E Maneiro M Tate EW
Acs Central Science,
American Chemical Society (Acs) vol. 6 (8), 1281-1284.
03-08-20202019
Synthesis and Structure‐Activity Relationships of N‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6De Vita E Smits N van den Hurk H Beck EM Hewitt J Baillie G Russell E Pannifer A et al.
Chemmedchem,
Wiley vol. 15 (1), 79-95.
18-11-2019
Design and Synthesis of Ionic Liquid‐Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI‐Coated Gold NanoparticlesD'Andrea F Nuti E Becherini S Cuffaro D Husanu E Camodeca C De Vita E Zocchi MR et al.
Chemmedchem,
Wiley vol. 14 (6), 686-698.
14-02-20192018
Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular ActivityDe Vita E Schüler P Lovell S Lohbeck J Kullmann S Rabinovich E Sananes A Heßling B et al.
Journal of Medicinal Chemistry,
American Chemical Society (Acs) vol. 61 (19), 8859-8874.
13-09-2018
A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringSananes A Cohen I Shahar A Hockla A De Vita E Miller AK Radisky ES Papo N
Journal of Biological Chemistry,
Elsevier vol. 293 (33), 12663-12680.
22-06-2018
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometryLonguespée R Wefers AK De Vita E Miller AK Reuss DE Wick W Herold-Mende C Kriegsmann M et al.
Acta Neuropathologica Communications,
Springer Nature vol. 6 (1)
02-03-2018
Discovery of stereoselective targeted covalent inhibitors of the RAB27-effector protein-protein interactionDe Vita E Thomas AM Brustur D Tersa M Petracca R Vadodaria S Briggs DA Houghton JW et al.
In
Biorxiv
Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACsShah RR De Vita E Conole D Sathyamurthi PS Zhang X Fellows E Fleites CM Queisser MA et al.
In
Biorxiv
A suite of activity-based probes to dissect the KLK activome in drug-resistant prostate cancerLovell S Zhang L Kryza T Neodo A Bock N Williams ED Engelsberger E Xu C et al.
In
Biorxiv
Synthesis and Structure–Activity Relationships of N-(4-Benzamidino)-Oxazolidinones–Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6De Vita E Smits N van den Hurk H Beck EM Hewitt J Baillie G Russell E Pannifer A et al.
In
Chemrxiv
Grants

Grants of specific relevance to the Centre for Molecular Cell Biology
Development of a microfluidic mechanodeformation platform for analysing force-dependent phosphorylation in living cellsElena De Vita and
Marc Fernandez-Yague£7,108
Biochemical Society15-06-2026 - 14-12-2027
Development of covalent probes for protein phosphatase 1 (PP1)Elena De Vita£11,000
Royal Society31-03-2024 - 30-09-2026
Covalent PHOSTACs for targeted protein dephosphorylation against K-Ras driven tumoursElena De Vita£69,401
Royal Society01-03-2024 - 31-08-2025
Research Group
PhD Students
- Hannes Giovanazzi
Directed Evolution of Photosystem II For Light-Driven Biocatalysis - Boman Li
Development of Covalent Ligands For Targeted Protein Dephosphorylation - Mark Mitchell
Covalent Phostacs For Targeted Dephosphorylation - Chimmy Nguyen
Illuminating The Dark Genome's Role in Chromosome Segregation and Cellular Aging - Kaichen Peng
Structural Studies of Bacterial DNA Replication Initiation Mechanism Using Cryo Electron Microscopy (Cryo-EM) and Novel Antibiotic Discovery - Tara Shutes
Chemical Biology Approaches to Study and Modulate Protein Phosphatases - Kexin Wang
Engineering Ubiquitin Ligases For Targeted Protein Degradation of Cancer-Associated Proteins - Charlotte Woolley
Cell Free Systems For Novel Antibiotics to Counter Antimicrobial Resistance
News
April 2026
30 April 2026
Researchers from the Centre for Molecular Cell Biology contributed to a study of cellular senescence published in the journal Nature Cell Biology.
Cellular senescence is a stress-response state in which cells permanently stop dividing but remain metabolically active, contributing to tissue repair and tumor suppression, while the accumulation of persistent ... [more]